[Clinical and immunological studies in patients with prostatic tumors].
The authors examined the cellular and humoral immune reactivity in patients with carcinomas of the prostate gland and determined several glycoproteins. The blastic transformation of lymphocytes was found significantly decreased. However, the concentrations of the immune globulins were not changed. Significantly changes were the glycoproteins belonging to the group of the "acute phase reactant proteins" and the complement titre in the serum. On account of the decreased immune reactivity the authors propose an immune therapy in the carcinoma of the prostate gland.
D000236:Adenoma / Q000276:immunology; D000368:Aged; D002277:Carcinoma / Q000276:immunology; D003165:Complement System Proteins / Q000032:analysis; D006023:Glycoproteins / Q000032:analysis; D006801:Humans; D007108:Immune Tolerance; D007136:Immunoglobulins / Q000032:analysis; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000276:immunology* / Q000473:pathology
D006023:Glycoproteins; D007136:Immunoglobulins; D003165:Complement System Proteins
Klinische und immunologische Untersuchungen bei Patienten mit Prostatatumoren.